AF
TCRT icon

Allworth Financial’s Alaunos Therapeutics TCRT Stock Holding History

Allworth Financial’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Hold
0
– – – 2376
2021
Q4 		– Sell
-39
Closed -$8.57K – 2114
2021
Q3 		$11K Buy
+39
New +$11.9K ﹤0.01% 1307

Other funds holding TCRT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Allworth Financial's TCRT Position: Q1 2022 in Review

Allworth Financial held its Alaunos Therapeutics (TCRT) position steady in Q1 2022 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2376.

Allworth Financial first reported a position in TCRT in Q3 2021 and has held it in 1 quarter since. The position peaked at $11K in Q3 2021. 148 funds tracked by Wall St. Rank hold TCRT as of Q1 2022.

  • Allworth Financial held 0 shares of Alaunos Therapeutics worth $0 as of Q1 2022.
  • Allworth Financial left its Alaunos Therapeutics share count unchanged in Q1 2022.
  • Alaunos Therapeutics made up ﹤0.01% of Allworth Financial's portfolio in Q1 2022, its #2376 holding.
  • Allworth Financial first reported a position in Alaunos Therapeutics in Q3 2021 and has held it in 1 quarter since.
  • Allworth Financial's Alaunos Therapeutics position peaked at $11K in Q3 2021.
  • 148 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q1 2022.

Based on Allworth Financial's 13F filing for Q1 2022, filed 22 Apr 2022.